Cleveland BioLabs Inc
CBLI
Market Cap$49.07M
Close$
$3.54
11.7% upside
Current Fair Value
11.7% upsideUndervalued by 11.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $49.07 Million |
|---|---|
| Enterprise Value | $35.29 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-0.19 |
| Beta | 1.52 |
| Outstanding Shares | 15,478,945 |
| Avg 30 Day Volume | 128,608 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -18.6 |
|---|---|
| PEG | -23.75 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 808.6 |
| Enterprise Value to EBIT | -12.74 |
| Enterprise Value to Net Income | -14 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
ESG Score
No data